Search results for "Venous Thromboembolism"


 
Results 51 - 60 of about 338 for "Venous Thromboembolism".
Sort by: Relevance | Newest | Oldest

COVID-19 flu guidance, data on convalescent plasma, cardiac effects, and clot risk

Flu testing and treatment advice came from the NIH, convalescent plasma failed in a trial, new studies suggested looking out for myocardial injury and not overdoing thromboprophylaxis, and remdesivir got full approval, among other COVID-19 news.
https://acphospitalist.acponline.org/weekly/archives/2020/10/28/1.htm
28 Oct 2020

Guidelines offer 28 recommendations for initial management, secondary prevention of DVT and PE

Among other recommendations, the new guidelines from the American Society of Hematology suggest offering home treatment to low-risk patients with deep venous thrombosis (DVT) or pulmonary embolism (PE).
https://acphospitalist.acponline.org/weekly/archives/2020/10/21/3.htm
21 Oct 2020

Puzzling it out together

Hospitalists share strategies for pandemic problems.
https://acphospitalist.acponline.org/archives/2020/10/puzzling-it-out-together.htm
15 Oct 2020

Syncope, sepsis resuscitation, and more

Research summaries from ACP Hospitalist Weekly.
https://acphospitalist.acponline.org/archives/2020/10/recent-research.htm
15 Oct 2020

MKSAP quiz on stroke

This month's quiz includes questions from ACP's Medical Knowledge Self-Assessment Program (MKSAP 18) on stroke.
https://acphospitalist.acponline.org/archives/2020/08/mksap-quiz-on-stroke.htm
15 Aug 2020

Decision pathway addresses bleeding in patients on oral anticoagulants

The guidance from the American College of Cardiology covers management of major and minor bleeding in patients treated with direct-acting oral anticoagulants or vitamin K antagonists for any indication.
https://acphospitalist.acponline.org/weekly/archives/2020/07/22/4.htm
22 Jul 2020

Rivaroxaban after discharge may reduce thromboembolic risk in medically ill

An industry-funded trial that gave medical patients rivaroxaban for 45 days after hospital discharge found decreased risk for a composite end point of symptomatic venous thromboembolism, myocardial infarction, nonhemorrhagic stroke, and cardiovascular death compared to placebo.
https://acphospitalist.acponline.org/weekly/archives/2020/06/24/3.htm
24 Jun 2020

MKSAP quiz on pulmonary embolism

This month's quiz includes questions from ACP's Medical Knowledge Self-Assessment Program (MKSAP 18) on pulmonary embolism.
https://acphospitalist.acponline.org/archives/2020/06/mksap-quiz-on-pulmonary-embolism.htm
15 Jun 2020

Guidelines, studies make recommendations on VTE prophylaxis for inpatients with COVID-19

A new CHEST guideline supports standard-dose anticoagulant thromboprophylaxis, while authors of two recent studies of hypercoagulability called for higher doses.
https://acphospitalist.acponline.org/weekly/archives/2020/06/10/2.htm
10 Jun 2020

test yourself 34 ACP Hospitalist • June 2020 CasE ...

Intravenous heparin. This patient should receive intravenous heparin. Venous throm-boembolism (VTE) is a common complication in patients with brain tumors, occurring in up to 30% of patients with high-grade ... to outpatient or inpatient care,. recurrent venous thromboembolism. (Vte) occurred within 90 days in 1.
https://acphospitalist.acponline.org/archives/2020/06/acph-202006-mksap-quiz-on-pulmonary-embolism_t1.pdf
28 May 2020

Result Page: Prev   1   2   3   4   5   6   7   8   9   10   Next